![Joseph Loscalzo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Loscalzo
Voorzitter bij
IONIS PHARMACEUTICALS, INC.
Vermogen: 3 M $ op 31-05-2026
Profiel
Dr. Joseph Loscalzo, MD PhD, is adviseur bij Mi3 Venture Partners Management LLC. Hij is Wade professor en voorzitter van de afdeling Geneeskunde, professor Biochemie, en directeur van het Whitaker Cardiovascular Institute aan de Boston University School of Medicine, alsmede hoofdarts van Boston Medical Center. Hij is een van de oprichters van NitroMed, Inc., zit in de Raad van Bestuur en is voorzitter van de Wetenschappelijke Adviesraad. In 2004 werd hij hoofdredacteur van Circulation, een toonaangevend wetenschappelijk tijdschrift voor cardiologie. Dr. Loscalzo behaalde zijn A.B. graad, summa cum laude, zijn Ph.D. in biochemie, en zijn M.D. aan de Universiteit van Pennsylvania. In 1984 trad hij toe tot de Harvard faculteit en de staf van het Brigham and Women's Hospital. In 1994 trad hij toe tot de faculteit van Boston University, eerst als hoofd cardiologie en, in 1997, als voorzitter geneeskunde. Dr. Loscalzo is voorzitter van de Cardiovasculaire Board van de American Board of Internal Medicine en voorzitter van de Board of Scientific Counselors van het NHLBI. Hij is gasthoogleraar geweest aan vele instellingen en is auteur of medeauteur van meer dan 400 wetenschappelijke publicaties en 20 boeken. Hij heeft ook vele subsidies van de NIH en het bedrijfsleven ontvangen voor zijn werk op het gebied van vasculaire biologie, trombose en atherosclerose in de afgelopen twintig jaar.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-05-2026 | 36.330 ( 0,02% ) | 3 M $ | 31-05-2026 | |
| 20-04-2026 | 168.750 ( 0,16% ) | 190 688 $ | 31-05-2026 |
Actieve functies van Joseph Loscalzo
| Bedrijven | Functie | Begin |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Voorzitter | 02-06-2021 |
| CYPHERPUNK TECHNOLOGIES INC. | Directeur/Bestuurslid | 01-01-2016 |
Brigham Medical Research & Educational Foundation, Inc. | President | - |
Brigham Community Practices, Inc. | Directeur/Bestuurslid | - |
Broadview Ventures, Inc.
 Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures invests in companies located across the globe, primarily in North America, Europe and Israel. The firm targets companies operating in the fields of healthcare and technology sectors. It provides financing for seed and early-stage capital requirements. The firm makes follow-on investments. | Consultant / Adviseur | - |
Scipher Medicine Corp.
 Scipher Medicine Corp. Miscellaneous Commercial ServicesCommercial Services Provides RNA data analysis for the treatment of autoimmune diseases and develops AI platform | Oprichter | 01-01-2013 |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Corporate Officer/Principal | - |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Corporate Officer/Principal | - |
| ░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
Eerdere bekende functies van Joseph Loscalzo
| Bedrijven | Functie | Einde |
|---|---|---|
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░ ░░ ░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Opleiding van Joseph Loscalzo
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
85
Eerstegraads connecties
25
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 25 |
|---|---|
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies pharmaceuticals | Health Technology |
Cardiovascular Sciences, Inc.
 Cardiovascular Sciences, Inc. Other Consumer ServicesConsumer Services Develops novel technology platform | Consumer Services |
TargAnox, Inc.
 TargAnox, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to prevent oxidative stress diseases | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Brigham & Women's Hospital, Inc.
The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
CB Health Ventures
 CB Health Ventures Investment ManagersFinance CB Health Ventures focuses on investment opportunities in healthcare services, medical information technology, biotechnology and genomics | Finance |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
American Heart Association, Inc.
 American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates a voluntary health organization | Commercial Services |
Brigham & Women's Faulkner Hospital, Inc.
 Brigham & Women's Faulkner Hospital, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that Provides health care services | Commercial Services |
Boston Medical Center
 Boston Medical Center Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
Mass General Brigham, Inc.
 Mass General Brigham, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit integrated healthcare system | Commercial Services |
American Board of Internal Medicine
 American Board of Internal Medicine Miscellaneous Commercial ServicesCommercial Services Operates self-appointed physician evaluation organization | Commercial Services |
Excel Medical Ventures LLC
 Excel Medical Ventures LLC Investment ManagersFinance Excel Medical Ventures invests in companies located in the United States. The firm focuses on companies operating in agriculture, energy, materials, IT, defense, healthcare sectors such as healthcare IT & services, diagnostics, medical devices, and life sciences platforms. It participates in early to late stage transactions. | Finance |
National Heart, Lung & Blood Institute
 National Heart, Lung & Blood Institute General GovernmentGovernment Promotes the prevention and treatment of heart, lung and blood diseases | Government |
Broadview Ventures, Inc.
Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures invests in companies located across the globe, primarily in North America, Europe and Israel. The firm targets companies operating in the fields of healthcare and technology sectors. It provides financing for seed and early-stage capital requirements. The firm makes follow-on investments. | Finance |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nivalis Therapeutics, Inc.
 Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of products for patients with cystic fibrosis | Health Technology |
Whitaker Cardiovascular Institute
 Whitaker Cardiovascular Institute The Whitaker Cardiovascular Institute is a research laboratory located in the Department of Medicine at Boston University School of Medicine. The lab focuses on studying endothelial cells and understanding vascular diseases, with a particular interest in the role of endothelial cells in the cardiovascular system. The company's research interests include understanding the molecular and cellular mechanisms that regulate vascular inflammation, endothelial dysfunction, pulmonary microvascular injury in sepsis, arterial vascular dysfunction, and atherosclerosis, developing non-invasive methods to measure in vivo vascular function, and exploring endothelial cell-targeted therapies for lung and cardiovascular diseases. The laboratory has a strong track record of research productivity and has expanded their research to cover topics such as cardiovascular physiopathology, redox biology, redOX proteomics, and optical vascular imaging. Whitaker Cardiovascular Institute is based in Boston, MA. | |
Scipher Medicine Corp.
Scipher Medicine Corp. Miscellaneous Commercial ServicesCommercial Services Provides RNA data analysis for the treatment of autoimmune diseases and develops AI platform | Commercial Services |
Leap Therapeutics, Inc.
 Leap Therapeutics, Inc. BiotechnologyHealth Technology Engages in clinical stage immuno-oncology | Health Technology |
Brigham Community Practices, Inc. | |
Brigham Medical Research & Educational Foundation, Inc. |
